Symptom severity and disease activity indices for diverticulitis

Journal of Clinical Gastroenterology

Volumn 42, Issue 10, 2008, Pages 1135-1136

  Floch, Martin H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diverticular disease; Diverticulitis; Monitoring symptoms

Indexed keywords

ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COLON DIVERTICULOSIS; DEFECATION HABIT; DISEASE ACTIVITY; DISEASE SEVERITY; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL; DISEASE COURSE; DIVERTICULITIS; HOSPITALIZATION; PATHOPHYSIOLOGY; REVIEW;

DISEASE PROGRESSION; DIVERTICULITIS; HUMANS; SEVERITY OF ILLNESS INDEX;

EID: 58149269606     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e318188b1bc     Document Type: Article

References (15)

1. Almy TP, Howell DA. Diverticular disease of the colon. N Engl J Med. 1980;302:324-331.
2. Drossman DA, Corazziari E, Delvaux M, et al. Rome III. The Functional Gastrointestinal Disorders. 3rd ed. McLean, VA: Degnon Associates Inc; 2006:1-29.
3. Kohler L, Sauerland S, Neugebauer E. Diagnosis and treatment of diverticular disease: results of a consensus development conference. Surg Endosc. 1999;13:430-436.
4. Stollman N, Raskin JB. Diverticular disease of the colon. Lancet. 2004;363:631-639.
5. Sheth AA, Longo W, Floch MH. Diverticular disease and diverticulitis. Am J Gastroenterol. 2008;103:1550-1556.
6. Clemens CHM, Samsom M, Roelofs J, et al. Colorectal visceral perception in diverticular disease. Gut. 2004;53:717-722.
7. Parks TG, Connell AM. Motility studies in diverticular disease of the colon. Gut. 1969;10:534-542.
8. Trotman IF, Misiewicz JJ. Sigmoid motility in diverticular disease and the irritable bowel syndrome. Gut. 1988;29:218-222.
9. Painter NS, Truelove SC. The intraluminal pressure patterns in diverticulosis of the colon. Gut. 1964;5:201-213.
10. Smith AN. Colonic muscle in diverticular disease. Clin Gastroenterol. 1986;15:917-935.
11. West AB. The pathology of diverticulosis: classical concepts and mucosal changes in diverticula. J Clin Gastronterol. 2006;40: S126-S131.
12. Trespi E, Colla C, Panizza P, et al. Therapeutic and prophylactic role of mesalazine (5-ASA) in symptomatic diverticular disease of the large intestine. 4-year follow-up results. Minerva Gastroenterol Dietol. 1999;45:245-252.
13. Tursi A, Brandimarte G, Daffina R. Long-term treatment with mesalazine and rifaximin versus rifaximin alone for the patients with recurrent attacks of acute diverticulitis of the colon. Digest Liver Dis. 2002;34:510-515.
14. Di Mario F, Comparato G, Fanigliulo L, et al. Use of mesalazine in diverticular disease. J Clin Gastroenterol. 2006;40:S155-S159.
15. Comparato G, Fanigliulo L, Cavallaro LG, et al. Prevention of complications and symptomatic recurrences in diverticular disease with mesalamine: a 12-month follow-up. Dig Dis Sci. 2007;52: 2934-2941.